
Bitter pill: Cuba runs low on life-saving medicines
Rodriguez, who left her job as a physiotherapist to care for her sickly son, receives a monthly state grant of less than $12. Her husband's salary is not much more.
And as Cuba sinks ever deeper into its worst economic crisis in decades -- with critical shortages also of food and fuel, regular power blackouts and rampant inflation -- Rodriguez fears that one day the drugs may run out altogether.
"It drives me crazy," the 27-year-old told AFP at her home in Havana's Santa Fe neighborhood as her son Luis Angelo, watched a cartoon on her mobile.
"Missing a dose, not having the suction tubes, a catheter that cannot be replaced... all can lead to serious illnesses which can cost him his life."
Luis Angelo was born with a deformed esophagus, and while he waits to receive a transplant, breathes through a tracheostomy and eats though a tube inserted into his stomach. He is also asthmatic, has a heart condition, and suffers epileptic fits.
The boy takes seven different drugs daily, and needs a variety of tubes, syringes and other equipment to administer them.
Cuba, reputed for supplying highly trained medical doctors to other countries and for its advanced domestic pharmaceutical industry, has long counted vaccines and medical services among its top exports.
Under US sanctions since 1962, and hard hit by the COVID-19 pandemic that all but tanked its tourism industry, the communist country is now no longer medically self-sufficient.
Last year, the island nation of 9.7 million people could not afford the $300 million needed to import the raw materials it needed to produce hundreds of critical medicines.
'There's nothing'
In Havana, and further afield, pharmacy shelves are bare and hospitals lack basic supplies such as gauze, suturing thread, disinfectant and oxygen.
"There are days when there's nothing," a doctor in the capital told AFP on condition of anonymity.
Cuba's healthcare system is public and meant to be universally accessible. Private pharmacies, clinics and hospitals are illegal.
Patients who require chronic medicine are issued with a document known as a "tarjeton," which allows them access to subsidized medicines.
Luis Angelo has a "tarjeton," but it is of little use if pharmacies don't have the drugs, said his mom.
On the black market, she is forced to pay $3 to $4 for a blister sheet of pills -- about a quarter of the average monthly Cuban salary at the unofficial exchange rate.
"The price is cruel," Rodriguez told AFP.
'Ray of hope'
Confronted with the ever-worsening medicine shortage, the government has since 2021 allowed travelers to bring back food and medicines in their luggage -- though not for resale.
Some of these drugs are feeding a black market that profits from the desperately infirm with sales via WhatsApp or internet sites.
Other sites, however, offer drugs for free or barter them for food.
In the NGO sphere, projects have also emerged to provide medicines to Cubans free of charge.
One, dubbed Palomas, has helped tens of thousands of people since its creation in Havana in 2021.
It relies on medicines that people have "left over from a treatment, or were brought by someone from abroad," coordinator Sergio Cabrera told AFP.
Every day, in 13 WhatsApp groups, Palomas publishes a list of medicines it has available, and another list of those it needs.
One beneficiary was 32-year-old dentist Ibis Montalban, who said she managed to get her mother's chronic diabetes medication through Palomas, adding: "thank you, thank you, thank you."
Cabrera says it is hard to witness the suffering of people in need.
"Many people cry here, and many times we cry with them," he said, grateful that Palomas can at least offer " a ray of hope."
© 2025 AFP
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


France 24
04-08-2025
- France 24
Doctors fight vaccine mistrust as Romania hit by measles outbreak
With measles cases in Europe hitting a 25-year high last year, Romania was the country most affected: it recorded 13,000 of the approximately 18,000 cases registered between June 2024 and May 2025 in the European Economic Area, which includes EU members as well as Iceland, Liechtenstein and Norway. But the disease has also re-emerged globally, with the United States confronting its worst epidemic in 30 years, in part fuelled by anti-vaccine misinformation that has been circulating on social media since the Covid-19 pandemic. Despite widespread vaccine scepticism in Romania, Gafita and her colleagues from the local health department are undeterred in their mission to spread the immunisation message. "We are trying to recover little by little what we lost" in the past decades when the situation was still at bay, said the 52-year-old. Romania has the EU's lowest vaccination rate at 62 percent, a far cry from the 95 percent the World Health Organization (WHO) says is needed for effective control. Irrational fear But it's a fight on many fronts, due not only to poverty but also poor access to health care and persistent rumours that vaccination causes autism. "I heard the vaccine is dangerous," said a woman, who declined to give her name, in the village of Raucesti. Elena Armenia, who also lives in the village of 7,500 people, told AFP that she did not want her youngest child to be vaccinated after reading "about a link to autism" online, a misconception that has been refuted by the scientific community. "Fear crept into my mind and I can't shake it off," said the 34-year-old. Her neighbours' children recently ended up in hospital after contracting measles, a contagious disease that causes fever, respiratory symptoms and a rash -- but can also lead to pneumonia, brain inflammation and even death. Romania reported eight fatalities from measles between June 2024 to May 2025. In July, a child died in Britain, with three deaths being recorded in the United States this year. Family doctor Monica Apostol told AFP that she was less optimistic than some of her colleagues about Romania's vaccination rate being boosted soon. "I'm hitting a brick wall," she said about her many conversations with parents. Far-right anti-vaxers Several factors have contributed to lower vaccination rates and subsequently to the resurgence of measles in Romania, where jabs are offered for free but are not mandatory. Millions of Romanians, including many health professionals, left the country after the end of communism in 1989. Moreover, the country has seen periods of vaccine shortages, but also an underfunded healthcare system and an increasing lack of trust in authorities. During the Covid pandemic, public figures in Romania but also worldwide began launching or endorsing anti-vaccination campaigns, with US President Donald Trump appointing Robert F. Kennedy Jr as health secretary despite his support of anti-vaccine conspiracy theories. Romania's far right also seized on anger over strict pandemic measures and started promoting anti-vaccine beliefs. Far-right leader George Simion, who topped the first round of the presidential election in May before losing in the second round, has said that parents should have the freedom to decide whether to have their children vaccinated or not. Pro-European President Nicusor Dan recently called on authorities to redouble their efforts to "regain people's trust", and combat a deluge of conspiracy theories and fake news that has eroded confidence. "The recent elections have shown that misinformation campaigns are conducted in a highly professional manner," said Gindrovel Dumitra, coordinator for vaccinations at one of Romania's main doctors' associations. Faced with a situation that is "out of control", his colleague Gafita advocates for tougher nationwide rules, including the need for children to be vaccinated to be able to attend school. © 2025 AFP


France 24
31-07-2025
- France 24
Trump's tariffs deadline looms
Also, in Nigeria's capital Abuja, nurses have launched a seven-day strike over pay and working conditions, deepening the city's healthcare crisis. Talks with the government collapsed, prompting walkouts that have crippled hospitals. The strike follows a wave of unrest over rising living costs after President Bola Tinubu's economic reforms. While the government plans to meet union reps, frustration grows among patients and health workers alike. Finally, in the Central African Republic, crumbling infrastructure and soaring energy prices have sparked a surge in illegal electricity connections. A dangerous trend that has resulted in deadly fires and electrocutions. The latest catastrophe led to a stampede that claimed the lives of nearly 30 students. The stakes have never been higher.


France 24
24-07-2025
- France 24
Pharma giant Roche sees income soar in first half
It also reported that four potentially "practice-changing" drugs -- to treat Alzheimer's, Parkinson's, haemophilia and an antibiotic to fight a drug-resistant bacteria strain -- had advanced to the final stage of clinical development. Net income jumped 17 percent to reach 7.8 billion Swiss francs ($9.85 billion), while the Basel-based group confirmed its full-year outlook. Its sales exceeded forecasts, rising four percent to 30.9 billion Swiss francs -- or a seven-percent hike excluding currency effects, the world leader in cancer treatments said in a statement. Roche has two branches: pharmaceuticals and diagnostics. Its pharmaceuticals division saw sales rise 10 percent, at constant exchange rates, to 24 billion francs, primarily thanks to five "growth driver" medicines, including for breast cancer and asthma, which achieved total sales of 10.6 billion francs. That was 1.7 billion more than during the first half of 2024. Sales in its diagnostics division, however, were flat at constant exchange rates, at 6.95 billion francs. "We received numerous important approvals and reported positive data in disease areas with high unmet medical need," said Roche chief executive Thomas Schinecker. "Over the past six months, we have made significant progress in our pipeline and advanced four potentially practice-changing therapies into the final phase of clinical development," he said. These are NXT007 in haemophilia A, trontinemab in Alzheimer's disease, prasinezumab in early-stage Parkinson's disease, and zosurabalpin, "a novel antibiotic that could become the first in over 50 years to tackle a type of bacteria that has become resistant to most other treatments". For the full year, Roche said it was still targeting mid-single-digit sales growth excluding currency effects, equivalent to around five percent growth. In April, Roche announced plans to invest $50 billion in the United States over the next five years, following in the footsteps of Swiss rival Novartis, with US President Donald Trump's tariff war fuelling uncertainty in the sector. The United States is a key market for the pharmaceutical industry, representing around half of sales in Roche's pharmaceutical division.